Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?

BACKGROUND: Tumour budding (TB) and Tumour Stroma Ratio (TSR) may be rewarding in the treatment stratification of patients with stage II colon cancer. However, lack of standardization may exclude these parameters from being used in a clinical setting. The purpose of this methodologic study was to co...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksen, Ann C., Andersen, Johnnie B., Lindebjerg, Jan, dePont Christensen, René, Hansen, Torben F., Kjær-Frifeldt, Sanne, Sørensen, Flemming B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859415/
https://www.ncbi.nlm.nih.gov/pubmed/29558947
http://dx.doi.org/10.1186/s13000-018-0697-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859415/
https://www.ncbi.nlm.nih.gov/pubmed/29558947
http://dx.doi.org/10.1186/s13000-018-0697-9

Ejemplares similares